The AI Revolution in Biotech: A Watershed Moment for Medicine Perth based Syngenis Laboratories is at the forefront of a significant convergence between biotechnology and artificial intelligence, one that promises to revolutionize medicine.
The company has launched its AI powered discovery platform, Syngenis Discovery, which harnesses machine learning to accelerate the search for next generation therapies and diagnostic molecules.
A Biotech Bottleneck Solved? Traditional drug development is often a laborious process, taking months or even years to identify viable treatments from an overwhelming number of potential molecular combinations.